Details of the Drug

General Information of Drug (ID: DM3N6ME)

Drug Name

MDR-102

Indication

Disease Entry	ICD 11	Status	REF
Kidney transplant rejection	NE84	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03605654) Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants. U.S. National Institutes of Health.